Post-transplant Cyclophosphamide (PTCy) for HLA-Matched Hematopoietic Stem Cell Transplant (HCT) in Pediatric and Young Adult Patients with Hematologic Malignancies
- 27 February 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (7) , 883.e1-883.e8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2022
- Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyTransplantation and Cellular Therapy, 2021
- An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCTTransplantation and Cellular Therapy, 2021
- Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute LeukemiaTransplantation and Cellular Therapy, 2018
- Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow TransplantationTransplantation and Cellular Therapy, 2018
- Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic MalignanciesTransplantation and Cellular Therapy, 2016
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease TrialTransplantation and Cellular Therapy, 2013
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Prevention of cyclophosphamide-induced hemorrhagic cystitisUrology, 1982